153 related articles for article (PubMed ID: 31569615)
81. Establishment and characterization of NCC-DMM1-C1, a novel patient-derived cell line of desmoplastic malignant pleural mesothelioma.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Motoi N; Yatabe Y; Yoshida Y; Watanabe S; Kondo T
Oncol Lett; 2022 Feb; 23(2):64. PubMed ID: 35069873
[TBL] [Abstract][Full Text] [Related]
82.
Doi T; Ogawa H; Tanaka Y; Hayashi Y; Maniwa Y
Oncol Lett; 2020 Dec; 20(6):362. PubMed ID: 33133262
[TBL] [Abstract][Full Text] [Related]
83. Sound-based assembly of a microcapillary network in a saturn-like tumor model for drug testing.
Di Marzio N; Ananthanarayanan P; Guex AG; Alini M; Riganti C; Serra T
Mater Today Bio; 2022 Dec; 16():100357. PubMed ID: 35880098
[TBL] [Abstract][Full Text] [Related]
84. 3D spheroid culture to examine adaptive therapy response in invading tumor cells.
Weiss F; Atlasy N; van Reijmersdal V; Stunnenberg H; Hulsbergen-Veelken C; Friedl P
In Vitro Model; 2022; 1(6):463-471. PubMed ID: 37096022
[TBL] [Abstract][Full Text] [Related]
85. Automated Analysis of Extracellular Matrix Invasion of Cancer Cells from Tumor Spheroids.
Heiss J; Tavana H
ACS Meas Sci Au; 2024 Jun; 4(3):260-266. PubMed ID: 38910858
[TBL] [Abstract][Full Text] [Related]
86. Real-Time Fluorescence Visualization and Quantitation of Cell Growth and Death in Response to Treatment in 3D Collagen-Based Tumor Model.
Sencha LM; Dobrynina OE; Pospelov AD; Guryev EL; Peskova NN; Brilkina AA; Cherkasova EI; Balalaeva IV
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012102
[TBL] [Abstract][Full Text] [Related]
87. The investigation of effects of quercetin and its combination with Cisplatin on malignant mesothelioma cells in vitro.
Demiroglu-Zergeroglu A; Basara-Cigerim B; Kilic E; Yanikkaya-Demirel G
J Biomed Biotechnol; 2010; 2010():851589. PubMed ID: 20508819
[TBL] [Abstract][Full Text] [Related]
88. Pemetrexed and cisplatin-induced linear hyperpigmentation of skin.
Vashisht D; Sharma N; Sood A; Baveja S
Med J Armed Forces India; 2020 Jul; 76(3):353-355. PubMed ID: 32773943
[No Abstract] [Full Text] [Related]
89. Cell and extracellular matrix interaction models in benign mesothelial and malignant pleural mesothelioma cells in 2D and 3D in-vitro.
Jagirdar RM; Papazoglou ED; Pitaraki E; Kouliou OA; Rouka E; Giannakou L; Giannopoulos S; Sinis SI; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):543-552. PubMed ID: 33336399
[TBL] [Abstract][Full Text] [Related]
90. Complex in vitro Model: A Transformative Model in Drug Development and Precision Medicine.
Wang L; Hu D; Xu J; Hu J; Wang Y
Clin Transl Sci; 2023 Dec; 17(2):. PubMed ID: 38062923
[TBL] [Abstract][Full Text] [Related]
91. Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?
Gao Y; Kruithof-de Julio M; Peng RW; Dorn P
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954422
[TBL] [Abstract][Full Text] [Related]
92. Preparation of Spheroids from Primary Pig Cells in a Mid-Scale Bioreactor Retaining Their Myogenic Potential.
Stange K; Keric A; Friese A; Röntgen M
Cells; 2022 Apr; 11(9):. PubMed ID: 35563757
[TBL] [Abstract][Full Text] [Related]
93. Optimization of tumor spheroid model in mesothelioma and lung cancers and anti-cancer drug testing in H2052/484 spheroids.
Gendre DAJ; Ameti E; Karenovics W; Perriraz-Mayer N; Triponez F; Serre-Beinier V
Oncotarget; 2021 Nov; 12(24):2375-2387. PubMed ID: 34853659
[TBL] [Abstract][Full Text] [Related]
94. Cancer Organoids in Basic Science and Translational Medicine.
Memeo L; Canzonieri V; Rizzolio F
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359607
[TBL] [Abstract][Full Text] [Related]
95. Use of preclinical models for malignant pleural mesothelioma.
Shamseddin M; Obacz J; Garnett MJ; Rintoul RC; Francies HE; Marciniak SJ
Thorax; 2021 Nov; 76(11):1154-1162. PubMed ID: 33692175
[TBL] [Abstract][Full Text] [Related]
96. Normal mesothelial cell lines newly derived from human pleural biopsy explants.
Pruett N; Singh A; Shankar A; Schrump DS; Hoang CD
Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L652-L660. PubMed ID: 32726133
[TBL] [Abstract][Full Text] [Related]
97. In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes.
Papazoglou ED; Jagirdar RM; Kouliou OA; Pitaraki E; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569615
[TBL] [Abstract][Full Text] [Related]
98. 2-Deoxy-glucose Enhances the Effect of Cisplatin and Pemetrexed in Reducing Malignant Pleural Mesothelioma Cell Proliferation But Not Spheroid Growth.
Gerogianni I; Pitaraki E; Jagirdar RM; Kouliou O; Giannakou L; Giannopoulos S; Papazoglou E; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
Anticancer Res; 2019 Jul; 39(7):3809-3814. PubMed ID: 31262908
[TBL] [Abstract][Full Text] [Related]
99. Effects of pharmacological primary cilium disturbance in the context of in vitro 2D and 3D malignant pleura mesothelioma.
Jagirdar RM; Pitaraki E; Kotsiou OS; Rouka E; Sinis SI; Varsamas C; Marnas P; Stergiopoulou E; Giannou A; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
Biochem Biophys Res Commun; 2023 Apr; 654():128-135. PubMed ID: 36907140
[TBL] [Abstract][Full Text] [Related]
100. Influence of AQP1 on cell adhesion, migration, and tumor sphere formation in malignant pleural mesothelioma is substratum- and histological-type dependent.
Jagirdar RM; Apostolidou E; Molyvdas PA; Gourgoulianis KI; Hatzoglou C; Zarogiannis SG
Am J Physiol Lung Cell Mol Physiol; 2016 Mar; 310(6):L489-95. PubMed ID: 26773069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
